[Targeting of nitric oxide-donor and related drugs].
Zhang
Yi-Hua
YH
Center of Drug Discovery, China Pharmaceutical University, Nanjing 210009, China. zyhtgd@hotmail.com
Tian
Ji-De
JD
Peng
Si-Xun
SX
D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D001391:Azo Compounds / Q000138:chemical synthesis / Q000494:pharmacology; D045744:Cell Line, Tumor; D016503:Drug Delivery Systems; D006801:Humans; D008099:Liver / Q000378:metabolism; D008113:Liver Neoplasms / Q000473:pathology; D009566:Nitrates / Q000138:chemical synthesis / Q000494:pharmacology; D020030:Nitric Oxide Donors / Q000138:chemical synthesis / Q000494:pharmacology; D009828:Oleanolic Acid / Q000031:analogs & derivatives / Q000138:chemical synthesis / Q000494:pharmacology; D010879:Piperazines / Q000138:chemical synthesis / Q000494:pharmacology; D014580:Ursodeoxycholic Acid / Q000031:analogs & derivatives / Q000138:chemical synthesis / Q000494:pharmacology
C433771:2-methyl-3-(2-((4-nitrooxybutyloxy)carbonyl)vinyl)phenyl ursodeoxycholic acid ester; D001391:Azo Compounds; D009566:Nitrates; D020030:Nitric Oxide Donors; C474958:O(2)-(2,4-dinitrophenyl) 1-((4-ethoxycarbonyl)piperazin-1-yl)diazen-1-ium-1,2-diolate; D010879:Piperazines; D009828:Oleanolic Acid; D014580:Ursodeoxycholic Acid